0001209191-23-057258.txt : 20231204 0001209191-23-057258.hdr.sgml : 20231204 20231204170026 ACCESSION NUMBER: 0001209191-23-057258 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231204 DATE AS OF CHANGE: 20231204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Puttagunta Sailaja CENTRAL INDEX KEY: 0001792314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38503 FILM NUMBER: 231464084 MAIL ADDRESS: STREET 1: C/O BIOMX LTD. STREET 2: 7 PINHAS SAPIR ST., FLOOR 2 CITY: NESS ZIONA STATE: L3 ZIP: 7414002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Iterum Therapeutics plc CENTRAL INDEX KEY: 0001659323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FITZWILLIAM COURT, 1ST FLOOR STREET 2: LEESON CLOSE CITY: DUBLIN 2 STATE: L2 ZIP: D02 YW24 BUSINESS PHONE: (872) 225-6077 MAIL ADDRESS: STREET 1: FITZWILLIAM COURT, 1ST FLOOR STREET 2: LEESON CLOSE CITY: DUBLIN 2 STATE: L2 ZIP: D02 YW24 FORMER COMPANY: FORMER CONFORMED NAME: Iterum Therapeutics Ltd DATE OF NAME CHANGE: 20151124 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-01 0 0001659323 Iterum Therapeutics plc ITRM 0001792314 Puttagunta Sailaja C/O ITERUM THERAPEUTICS PLC FITZWILLIAM COURT, FL. 1, LEESON CLOSE DUBLIN 2 L2 IRELAND 0 1 0 0 Chief Medical Officer 0 Ordinary Shares 2023-12-01 4 A 0 8333 0.00 A 13302 D Ordinary Shares 2023-12-01 4 F 0 2933 2.12 D 10369 D Restricted Share Units 2023-12-01 4 M 0 8333 0.00 D Ordinary Shares 8333 16666 D On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split. Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs. Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs. The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split. On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022, with a further 25% having vested on December 1, 2023. /s/ Sailaja Puttagunta 2023-12-04